Noriyoshi Kurihara

  • 4324 Citations
  • 37 h-Index
1983 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Noriyoshi Kurihara is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants

  • Publications

    • 4324 Citations
    • 37 h-Index
    • 77 Article
    • 1 Chapter
    • 1 Review article

    Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo

    Miyagawa, K., Ohata, Y., Delgado-Calle, J., Teramachi, J., Zhou, H., Dempster, D. D., Subler, M. A., Windle, J. J., Chirgwin, J. M., David Roodman, G. & Kurihara, N., Mar 26 2020, In : JCI Insight. 5, 6, e133113.

    Research output: Contribution to journalArticle

    Open Access
  • Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts

    Delgado-Calle, J., Kurihara, N., Atkinson, E. G., Nelson, J., Miyagawa, K., Galmarini, C. M., Roodman, G. D. & Bellido, T., Apr 12 2019, In : Oncotarget. 10, 28, p. 2709-2721 13 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis

    Petrusca, D. N., Toscani, D., Wang, F. M., Park, C., Crean, C. D., Anderson, J. L., Marino, S., Mohammad, K. S., Zhou, D., Silbermann, R., Sun, Q., Kurihara, N., Galson, D. L., Giuliani, N. & Roodman, G. D., Oct 4 2018, In : Journal of Hematology and Oncology. 11, 1, 123.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Vitamin D and Paget's Disease

    Kurihara, N. & Roodman, G. D., Dec 14 2017, Health, Disease and Therapeutics. Elsevier Inc., Vol. 2. p. 571-579 9 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo

    Teramachi, J., Silbermann, R., Yang, P., Zhao, W., Mohammad, K. S., Guo, J., Anderson, J. L., Zhou, D., Feng, R., Myint, K. Z., Maertz, N., Beumer, J. H., Eiseman, J. L., Windle, J. J., Xie, X. Q., Roodman, G. D. & Kurihara, N., Feb 1 2016, In : Leukemia. 30, 2, p. 390-398 9 p.

    Research output: Contribution to journalArticle

  • 20 Scopus citations